Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-21-000203
Filing Date
2021-10-05
Accepted
2021-10-05 08:16:21
Documents
1
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4026
  Complete submission text file 0001013762-21-000203.txt   5551
Mailing Address 10555 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
STEINMAN LAWRENCE (Reporting) CIK: 0001132679 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 211305184

Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations